Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Jiangsu Province Hospital (The First Affiliated Hospital With Nanjing Medical University)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Iguratimod in Kidney Transplant Recipients

Not Applicable

Conditions: Kidney Transplantation

Interventions: Drug: Iguratimod
Drug: Mycophenolate mofetil
Drug: Tacrolimus
Drug: Glucocorticoids

First Posted Date: 2016-07-21

Last Posted Date: 2018-08-29

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 60

Registration Number: NCT02839941

Locations: 🇨🇳
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China

Microalbuminuria Predicting CIAKI After CAG

Conditions: Contrast-induced Acute Kidney Injury
Microalbuminuria

First Posted Date: 2016-06-22

Last Posted Date: 2016-06-22

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 800

Registration Number: NCT02808845

Locations: 🇨🇳
First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection

Conditions: Hepatitis B Virus Infection History
Liver Injury

First Posted Date: 2016-06-21

Last Posted Date: 2016-06-21

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 600

Registration Number: NCT02808299

Locations: 🇨🇳
First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)

Not Applicable

Conditions: Myelodysplastic Syndromes (MDS)

Interventions: Drug: decitabine

First Posted Date: 2016-05-20

Last Posted Date: 2017-11-08

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 80

Registration Number: NCT02779569

Locations: 🇨🇳
No.303 Hospital of Chinese People's Liberation Army, Nanning, Guangxi, China
🇨🇳
Jiangsu Province Hospital, Nanjing, Jiangsu, China
🇨🇳
Shengjing Hospital of China Medical Univercity, Shenyang, Liaoning, China

and more 3 locations

Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Phase 3

Conditions: Diffuse Large B Cell Lymphoma

Interventions: Drug: Rituximab
Drug: Cyclophosphamide
Drug: Gemcitabine
Drug: Epirubicin Injectable Product
Drug: Oxaliplatin
Drug: Vindesine
Drug: Prednisone

First Posted Date: 2016-05-10

Last Posted Date: 2019-01-03

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 258

Registration Number: NCT02767674

Locations: 🇨🇳
Tongji Medical College of HUST, Wuhan, Hubei, China
🇨🇳
The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), NanJing, Jiangsu, China
🇨🇳
QiLu Hospital of Shandong University, Jinan, Shandong, China

and more 3 locations

Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial

Phase 2

Terminated

Conditions: Esophageal

Interventions: Drug: "Endostar"
Drug: Liposo
Drug: cisplatin
Drug: Gimeracil and Oteracil Potassium （Tegafur）

First Posted Date: 2016-04-25

Last Posted Date: 2022-07-29

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 70

Registration Number: NCT02749526

Locations: 🇨🇳
The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Not Applicable

Conditions: Bladder Cancer
Gemcitabine and Cisplatin Chemotherapy
Epirubicin Instillation
Recurrence
Prognosis

Interventions: Drug: Gemcitabine, cisplatin

First Posted Date: 2016-03-23

Last Posted Date: 2016-03-24

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 208

Registration Number: NCT02716961

Locations: 🇨🇳
The first affiliated hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Dexmedetomidine for Cesarean Section

Phase 1

Completed

Conditions: Cesarean Section, Affecting Fetus or Newborn

Interventions: Drug: Placebo
Drug: Dexmedetomidine

First Posted Date: 2016-03-22

Last Posted Date: 2017-03-28

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 40

Registration Number: NCT02715154

Locations: 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

Open Versus Laparoscopic Complete Mesocolic Excision for Locally Advanced Colon Cancer

Phase 3

Conditions: Colon Cancer

First Posted Date: 2016-02-15

Last Posted Date: 2016-07-06

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 1080

Registration Number: NCT02682589

Locations: 🇨🇳
Jiangsu province hospital, Nanjing, Jiangsu, China

The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

Phase 4

Conditions: Atrial Fibrillation

Interventions: Drug: standard intensity warfarin
Drug: low intensity warfarin
Drug: dabigatran etexilate

First Posted Date: 2016-01-05

Last Posted Date: 2016-01-05

Lead Sponsor: The First Affiliated Hospital with Nanjing Medical University

Target Recruit Count: 210

Registration Number: NCT02646267

Locations: 🇨🇳
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy